Califf: More Expedited Approvals Mean US Clearance Only The Beginning Of Learning About Medical Products
The US FDA commissioner said increased use of expedited approval pathways will help spur clinical research system reform.

The US FDA commissioner said increased use of expedited approval pathways will help spur clinical research system reform.